Keryx Biopharma (KERX) Ticks Higher, Raymond James Said Positive on Auryxia Scripts
- Wall Street falls as bank, healthcare shares weigh
- Qualcomm (QCOM) Faces U.S. Antitrust Case Over Licensing - Bloomberg
- BAT Reaches Deal to Acquire Reynolds American (RAI) for $49 Billion
- Verizon Communications (VZ) May Acquire Big Cable Company - NYP (CHTR) (CMCSA)
- Citron Research Negative on Lannett (LCI); Sees Shares at 'Zero' Over Long Term
Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.
Keryx Biopharma (NASDAQ: KERX) Ticks Higher, Raymond James Said Positive on Auryxia Scripts
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UPDATE: JPMorgan Downgrades OneMain (OMF) to Neutral
- UPDATE: Stifel Upgrades Parkway Properties (PKY) to Hold
- Ionis Pharma (IONS): Cutting PT But Improving Fundamentals - BMO
Create E-mail Alert Related CategoriesAnalyst Comments, Trader Talk
Related EntitiesRaymond James
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!